...
首页> 外文期刊>AIDS Research and Human Retroviruses >Transmitted antiretroviral drug resistance and thumb subdomain polymorphisms among newly HIV type 1 diagnosed patients infected with CRF01-AE and CRF07-BC virus in Guangdong Province, China
【24h】

Transmitted antiretroviral drug resistance and thumb subdomain polymorphisms among newly HIV type 1 diagnosed patients infected with CRF01-AE and CRF07-BC virus in Guangdong Province, China

机译:中国广东省新诊断为1型HIV感染CRF01-AE和CRF07-BC病毒的患者的抗逆转录病毒耐药性和拇指亚域多态性

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The aim of this study was to elucidate the prevalence of transmitted drug-resistant (TDR) mutations and reverse transcriptase (RT) thumb subdomain polymorphisms in CRF01-AE and CRF07-BC virus among newly diagnosed, therapy-naive HIV-1 patients in Guangdong Province, China. One hundred and sixty-four samples were collected in the Guangzhou Eighth People's Hospital. The entire protease gene and 300 codons of the entry part of the reverse transcriptase were amplified and sequenced. Furthermore, genotypic drug resistance, polymorphisms, and their phylogeny were analyzed. According to eligibility criteria, seven samples were excluded, and 119 of 157 (75.8%) samples (84 CRF01-AE and 35 CRF07-BC) were amplified and sequenced successfully. The prevalence of TDR identified in the present study was 6.7% [8/119, 95% confidence interval (CI) 1.8-11.6%]. Three major resistance mutations, K103N, M184V, and Y188L, each of which caused more than one drug resistance, appeared in only two patients; the prevalence [1.7 % (2/119)] was relatively low. Until now, this is the first observation of the five newly identified accessory mutations, V35T, K43E, V60I, K122E, and E203D, and seven thumb subdomain polymorphisms, A272P, K277R, K281R, T286A, E291D, V292I, and I293V, in the RT gene in China. These findings provide useful information for guidance on the antiretroviral therapy (ART) policy in China where therapeutic options are still limited.
机译:这项研究的目的是阐明广东省新诊断,未接受治疗的HIV-1患者中CRF01-AE和CRF07-BC病毒的传播耐药性(TDR)突变和逆转录酶(RT)拇指亚域多态性的患病率中国的省。在广州市第八人民医院采集了164份标本。扩增完整的蛋白酶基因和逆转录酶入口部分的300个密码子并进行测序。此外,分析了基因型耐药性,多态性及其系统发育。根据合格标准,排除了七个样品,并成功扩增了157个样品中的119个(75.8%)(84个CRF01-AE和35个CRF07-BC)并测序。在本研究中确定的TDR患病率为6.7%[8 / 119,95%置信区间(CI)1.8-11.6%]。仅两名患者出现了三个主要的耐药性突变,即K103N,M184V和Y188L,每个突变均导致一种以上的耐药性。患病率[1.7%(2/119)]相对较低。到目前为止,这是对这五个新发现的辅助突变(V35T,K43E,V60I,K122E和E203D)以及七个拇指亚域多态性(A272P,K277R,K281R,T286A,E291D,V292I和I293V)的首次观察。中国的RT基因。这些发现为在治疗选择仍然有限的中国抗逆转录病毒疗法(ART)政策提供了有用的信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号